-
1
-
-
77956811462
-
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
-
A.J. Vickers, A.M. Cronin, and T. Björk Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study BMJ 341 2010 c4521
-
(2010)
BMJ
, vol.341
, pp. 4521
-
-
Vickers, A.J.1
Cronin, A.M.2
Björk, T.3
-
2
-
-
2442715038
-
Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter
-
I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
-
(2004)
N Engl J Med
, vol.350
, pp. 2239-2246
-
-
Thompson, I.M.1
Pauler, D.K.2
Goodman, P.J.3
-
3
-
-
77955981143
-
A four-kallikrein panel for the prediction of repeat prostate biopsy: Data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands
-
A. Gupta, M.J. Roobol, and C.J. Savage A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands Br J Cancer 103 2010 708 714
-
(2010)
Br J Cancer
, vol.103
, pp. 708-714
-
-
Gupta, A.1
Roobol, M.J.2
Savage, C.J.3
-
4
-
-
84856374086
-
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer
-
G. Guazzoni, M. Lazzeri, and L. Nava Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer Eur Urol 61 2012 455 466
-
(2012)
Eur Urol
, vol.61
, pp. 455-466
-
-
Guazzoni, G.1
Lazzeri, M.2
Nava, L.3
-
5
-
-
79953777963
-
A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range
-
W.J. Catalona, A.W. Partin, and M.G. Sanda A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range J Urol 185 2011 1650 1655
-
(2011)
J Urol
, vol.185
, pp. 1650-1655
-
-
Catalona, W.J.1
Partin, A.W.2
Sanda, M.G.3
-
6
-
-
79951626849
-
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening
-
A.J. Vickers, A. Gupta, and C.J. Savage A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening Cancer Epidemiol Biomarkers Prev 20 2011 255 261
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 255-261
-
-
Vickers, A.J.1
Gupta, A.2
Savage, C.J.3
|